HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Renaissance planning corporate restructuring following lower-than-expected results.

This article was originally published in The Rose Sheet

Executive Summary

RENAISSANCE CONSIDERING RESTRUCTURING BY END OF FY 1998 (March 31), following the company's Feb. 3 announcement that its third quarter operating results would be "significantly below" analysts' expectations. For the three months ending Dec. 31, the company expects net sales to be between $53 mil. and $55 mil., resulting in an operating loss before interest, taxes, depreciation and amortization of between $14 mil. and $16 mil., the fragrance and cosmetics marketer said. In response to the downturn, Renaissance said it is "reexamining" the business with the expectation that "underlying changes...will be important factors in our ability to operate successfully in the future."

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005103

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel